Have any questions?
+44 1234 567 890
THE MARKET IS CHANGING FUNDAMENTALLY. DO YOU KNOW WHERE YOUR COMPANY SHALL BE IN FIVE YEARS?
DR. ROLAND KNIELER
“When growth is an issue: whatever investment you want to make – in internationalisation, new products and technologies or an acquisition – basis are always the customer needs, the increasingly important regulatory assessment, market potentials, and a realistic estimate of time and costs. We combine the necessary know-how under one umbrella and thus make a difference. And lend you a fresh pair of eyes, which is often helpful when breaking new grounds.”
“Every product range has its own story and has grown over time. In times of the increasing regulatory complexity and rising costs for active ingredients and formulations, it is more reasonable than ever before to create strategic portfolios that are rooted in the customer’s requirements, and then initiate the necessary actions. What investment can you afford? What investment pays off? We will provide the overview that you need and help you take decisions that make economic sense.”
DR. GUNNAR KLEIST
Senior Expert Regulatory
“In the past, regulatory requirements primarily were a cost issue; this has fundamentally changed with the new EU Biocidal Products Regulation (BPR). The effects on the market, on the competitive environment, but also on your product range and on your relationship to active ingredient suppliers and authorities will be immense. While there were more than 1 000 active ingredients before BPR, the number has quartered until today. The same will happen with the formulations available on the market. New business models and co-operations will develop, new international competitors will crowd into your markets – but those who will invest wisely will profit by new opportunities. Let us take a look at your strategy – it will pay off.”
DR. JANA ZEILINGER
“Registrations and authorisations not only require a good deal of know-how, but also resources. Studies and expert opinions need to be commissioned at an early stage and accompanied carefully, for them to be available for authorisation in time. When country-specific requirements and submission deadlines are considered anticipatorily, you will benefit from a continuous marketability of your products, also during the assessment phase (market freeze). For this reason, it is essential to choose the right strategy and plan accordingly right from the beginning.”